Global Artificial Intelligence In Drug Repurposing Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Artificial Intelligence In Drug Repurposing Global Market Report 2025

Name: Artificial Intelligence In Drug Repurposing Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Component (Software And Platforms, Services), By Technology (Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision), By Deployment (Cloud-Based, On-Premises), By Therapeutic (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases), By End-User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence In Drug Repurposing Market Overview

• Artificial Intelligence In Drug Repurposing market size has reached to $0.87 billion in 2024

• Expected to grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%

• Growth Driver: Rising Demand For Precision Medicine Fueling The Growth Of The Market Due To Increasing Preference For Personalized And Targeted Therapies

• Market Trend: Accelerating Treatment Discovery Through Technology Integration

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Drug Repurposing Market?

Artificial intelligence in drug repurposing refers to the application of artificial intelligence techniques to identify new medical uses for existing drugs. It utilizes advanced data analytics, machine learning, and predictive modelling to analyse biological, chemical, and clinical data for potential therapeutic matches. This approach accelerates drug discovery, reduces research costs, and enhances the efficiency of pharmaceutical development.

The main components of artificial intelligence in drug repurposing include software and platforms and services. Software and platforms include digital tools and environments that enable the development, deployment, and use of applications and services. It uses various technologies such as machine learning or deep learning, natural language processing (NLP), knowledge graphs and network-based artificial intelligence, generative artificial intelligence and large language models (LLMs), and computer vision, and different deployment modes include cloud-based and on-premises. Various therapeutic areas include oncology, neurology, cardiovascular diseases, infectious diseases, immunology, metabolic disorders, and rare diseases and cater to several end-users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes, healthcare providers, and others.

Artificial Intelligence In Drug Repurposing Market Size and growth rate 2025 to 2029: Graph

What Is The Artificial Intelligence In Drug Repurposing Market Size 2025 And Growth Rate?

What Is The Artificial Intelligence In Drug Repurposing Market Growth Forecast?

The artificial intelligence in drug repurposing market size is expected to see exponential growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to growing demand for cost-effective drug development, increasing use of ai-powered predictive analytics, rising prevalence of complex diseases, growing adoption of cloud infrastructure and increasing repurposing opportunities for existing approved drugs. Major trends in the forecast period include innovations in machine learning and generative ai applications, developments in predictive modeling and data analytics, technological advancements in large language models for hypothesis generation, innovations in cloud-based ai drug discovery platforms and technological enhancements in multi-omics data integration systems.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Information Technology Industry?

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the information technology sector, particularly in hardware manufacturing, data infrastructure, and software deployment. Higher duties on imported semiconductors, circuit boards, and networking equipment have raised production and operational costs for tech firms, cloud service providers, and data centers. Companies relying on globally sourced components for laptops, servers, and consumer electronics are facing longer lead times and increased pricing pressures. In parallel, tariffs on specialized software tools and retaliatory measures from key international markets have disrupted global IT supply chains and reduced overseas demand for U.S.-developed technologies. To navigate these challenges, the sector is accelerating investments in domestic chip fabrication, diversifying supplier bases, and adopting AI-driven automation to enhance operational resilience and cost efficiency.

How Is The Artificial Intelligence In Drug Repurposing Market Segmented?

1) By Component: Software And Platforms, Services

2) By Technology: Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision

3) By Deployment: Cloud-Based, On-Premises

4) By Therapeutic: Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases

5) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users

Subsegments:

1) By Software And Platforms: Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools

2) By Services: Consulting Services, Data Management Services, Model Training And Optimization Services, Implementation And Integration Services, Support And Maintenance Services

What Is Driving The Artificial Intelligence In Drug Repurposing Market? Rising Demand For Precision Medicine Fueling The Growth Of The Market Due To Increasing Preference For Personalized And Targeted Therapies

The growing demand for precision medicine is expected to propel the growth of the artificial intelligence in drug repurposing market going forward. Precision medicine is a healthcare approach that customizes disease prevention and treatment based on an individual’s specific genes, behaviors, and environment. Rising demand for personalized treatments is driving the growth of precision medicine, as patients and healthcare providers increasingly seek therapies tailored to individual genetic and lifestyle profiles for improved effectiveness and reduced side effects. AI-driven drug repurposing enhances precision medicine by discovering existing drugs that align with an individual’s genetic or molecular characteristics, enabling more accurate and personalized treatment solutions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA granted approval for 16 personalized therapies targeting rare diseases in 2023, a notable rise compared to the six approvals issued in 2022. Therefore, the growing demand for precision medicine is driving the growth of the artificial intelligence in drug repurposing industry.

Who Are The Major Players In The Global Artificial Intelligence In Drug Repurposing Market?

Major companies operating in the artificial intelligence in drug repurposing market are IBM Corporation; Evogene Ltd.; Ginkgo Bioworks Holdings Inc.; BioAge Labs Inc.; Insilico Medicine Inc.; BostonGene Corporation; ISOMORPHIC LABS; Recursion Pharmaceuticals Inc.; Deep Genomics Inc.; Healx Ltd.; Owkin Inc.; BullFrog AI Holdings Inc.; Aicura Medical GmbH; Kantify; Ignota Labs Ltd.; OrphAI Therapeutics; Nabla Bio; Atomwise Inc.; BioXcel Therapeutics Inc.; Graph AI.

What Are The Key Trends Of The Global Artificial Intelligence In Drug Repurposing Market? Accelerating Treatment Discovery Through Technology Integration

Major companies operating in the artificial intelligence in drug repurposing market are focusing on the integration of advanced technologies in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using data-driven analysis of literature and biological information. A computational drug repositioning system refers to a technology-driven platform that uses artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2023, Tempus, a US-based provider of AI-based precision medicine solutions, announced a multi-year strategic collaboration with Recursion, a US-based clinical stage biotechnology company, valued at up to $160 million over five years. The collaboration provides Recursion with access to Tempus’ extensive library of de-identified, multimodal oncology data to support biomarker-driven therapeutic development. By leveraging Tempus’ large-scale patient datasets alongside Recursion’s AI-enabled discovery capabilities, the partnership strengthens oncology drug repurposing initiatives, demonstrating how advanced computational platforms combined with real-world clinical data can accelerate the discovery of new treatment opportunities.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market? Cosmos Health Incorporated Acquires Cloudscreen To Strengthen Artificial Intelligence (AI)-Driven Drug Repurposing Capabilities

In January 2024, Cosmos Health Inc., a US-based diversified healthcare company, acquired Cloudscreen for an undisclosed amount. Through this acquisition, Cosmos Health aims to enhance drug repurposing capabilities and accelerate the identification of new therapeutic applications for existing drugs. Cloudscreen is a US-based company specializing in AI-powered drug repurposing solutions.

What Is The Regional Outlook For The Global Artificial Intelligence In Drug Repurposing Market?

North America was the largest region in the artificial intelligence in drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence In Drug Repurposing Market?

The artificial intelligence in drug repurposing market includes revenues earned by entities by providing services such as predictive modelling, target identification, drug-disease interaction analysis, virtual screening, and clinical data mining. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence In Drug Repurposing Industry?

The artificial intelligence in drug repurposing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in drug repurposing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Artificial Intelligence In Drug Repurposing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.05 billion
Revenue Forecast In 2034	$2.19 billion
Growth Rate	CAGR of 20.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Component, Technology, Deployment, Therapeutic, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	IBM Corporation; Evogene Ltd.; Ginkgo Bioworks Holdings Inc.; BioAge Labs Inc.; Insilico Medicine Inc.; BostonGene Corporation; ISOMORPHIC LABS; Recursion Pharmaceuticals Inc.; Deep Genomics Inc.; Healx Ltd.; Owkin Inc.; BullFrog AI Holdings Inc.; Aicura Medical GmbH; Kantify; Ignota Labs Ltd.; OrphAI Therapeutics; Nabla Bio; Atomwise Inc.; BioXcel Therapeutics Inc.; Graph AI.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Artificial Intelligence In Drug Repurposing Market Characteristics

3. Artificial Intelligence In Drug Repurposing Market Trends And Strategies

4. Artificial Intelligence In Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Drug Repurposing Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence In Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence In Drug Repurposing Market Growth Rate Analysis

5.4. Global Artificial Intelligence In Drug Repurposing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence In Drug Repurposing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence In Drug Repurposing Total Addressable Market (TAM)

6. Artificial Intelligence In Drug Repurposing Market Segmentation

6.1. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software And Platforms

Services

6.2. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Machine Learning Or Deep Learning

Natural Language Processing (NLP)

Knowledge Graphs And Network-Based Artificial Intelligence

Generative Artificial Intelligence And Large Language Models (LLMs)

Computer Vision

6.3. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cloud-Based

On-Premises

6.4. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurology

Cardiovascular Diseases

Infectious Diseases

Immunology

Metabolic Disorders

Rare Diseases

6.5. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Companies

Contract Research Organizations (CROs)

Academic And Research Institutes

Healthcare Providers

Other End-Users

6.6. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Predictive Analytics Tools

Machine Learning Frameworks

Data Integration Systems

Drug Discovery Platforms

Clinical Trial Simulation Tools

6.7. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consulting Services

Data Management Services

Model Training And Optimization Services

Implementation And Integration Services

Support And Maintenance Services

7. Artificial Intelligence In Drug Repurposing Market Regional And Country Analysis

7.1. Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Drug Repurposing Market

8.1. Asia-Pacific Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Drug Repurposing Market

9.1. China Artificial Intelligence In Drug Repurposing Market Overview

9.2. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Drug Repurposing Market

10.1. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Drug Repurposing Market

11.1. Japan Artificial Intelligence In Drug Repurposing Market Overview

11.2. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Drug Repurposing Market

12.1. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Drug Repurposing Market

13.1. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Drug Repurposing Market

14.1. South Korea Artificial Intelligence In Drug Repurposing Market Overview

14.2. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Drug Repurposing Market

15.1. Western Europe Artificial Intelligence In Drug Repurposing Market Overview

15.2. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Drug Repurposing Market

16.1. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Drug Repurposing Market

17.1. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Drug Repurposing Market

18.1. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Drug Repurposing Market

19.1. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Drug Repurposing Market

20.1. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Drug Repurposing Market

21.1. Eastern Europe Artificial Intelligence In Drug Repurposing Market Overview

21.2. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Drug Repurposing Market

22.1. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Drug Repurposing Market

23.1. North America Artificial Intelligence In Drug Repurposing Market Overview

23.2. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Drug Repurposing Market

24.1. USA Artificial Intelligence In Drug Repurposing Market Overview

24.2. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Drug Repurposing Market

25.1. Canada Artificial Intelligence In Drug Repurposing Market Overview

25.2. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Drug Repurposing Market

26.1. South America Artificial Intelligence In Drug Repurposing Market Overview

26.2. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Drug Repurposing Market

27.1. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Drug Repurposing Market

28.1. Middle East Artificial Intelligence In Drug Repurposing Market Overview

28.2. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Drug Repurposing Market

29.1. Africa Artificial Intelligence In Drug Repurposing Market Overview

29.2. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence In Drug Repurposing Market Competitive Landscape

30.2. Artificial Intelligence In Drug Repurposing Market Company Profiles

30.2.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Evogene Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Ginkgo Bioworks Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. BioAge Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Drug Repurposing Market Other Major And Innovative Companies

31.1. BostonGene Corporation

31.2. ISOMORPHIC LABS

31.3. Recursion Pharmaceuticals Inc.

31.4. Deep Genomics Inc.

31.5. Healx Ltd.

31.6. Owkin Inc.

31.7. BullFrog AI Holdings Inc.

31.8. Aicura Medical GmbH

31.9. Kantify

31.10. Ignota Labs Ltd.

31.11. OrphAI Therapeutics

31.12. Nabla Bio

31.13. Atomwise Inc.

31.14. BioXcel Therapeutics Inc.

31.15. Graph AI

32. Global Artificial Intelligence In Drug Repurposing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market

34. Recent Developments In The Artificial Intelligence In Drug Repurposing Market

35. Artificial Intelligence In Drug Repurposing Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence In Drug Repurposing Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence In Drug Repurposing Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence In Drug Repurposing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: IBM Corporation Financial Performance

Table 79: Evogene Ltd. Financial Performance

Table 80: Ginkgo Bioworks Holdings Inc. Financial Performance

Table 81: BioAge Labs Inc. Financial Performance

Table 82: Insilico Medicine Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: IBM Corporation Financial Performance

Figure 79: Evogene Ltd. Financial Performance

Figure 80: Ginkgo Bioworks Holdings Inc. Financial Performance

Figure 81: BioAge Labs Inc. Financial Performance

Figure 82: Insilico Medicine Inc. Financial Performance

Explore growth forecasts and key drivers in the global self-learning AI and reinforcement learning market.

Explore how serverless architecture is revolutionizing the global serverless computing platforms market.

Get insights on the global Kitchen Remodel Services Market including latest trends, forecasts, and key statistics from The Business Research Company.

Get insights on the global LLMs In Cybersecurity Market including latest trends, forecasts, and key statistics from The Business Research Company.

Password Based Authentication Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

How the Passwordless Authentication Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)

Perimeter Intrusion Detection and Prevention Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Point Of Sale System Requirement Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025 – By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Q...

Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025 – By Offering (Hardware, Software, Services), By Deployment (Cloud, On-Premises), By Technology (Machine Learning, Natural Language Processing,...

Artificial Intelligence In Medicine Global Market Report 2025 – By Type (Hardware, Software, Services), By Technology ( Machine Learning, Natural Language Processing, Context-Aware Processing, Computer Vision), By Applic...

Pharmacy Repackaging Systems Global Market Report 2025 – By Type (Blister Card Packaging Systems, Pouch Packaging Automation Systems, Liquid Medication Packaging Systems, Bottle Filling Automation Systems), By Dosage Typ...

Lab Automation In Drug Discovery Global Market Report 2025 – By Type (Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types), By Component (Instruments, S...

Machine Learning (ML) in The Pharmaceutical Industry Global Market Report 2025 – By Component (Solution, Services), By Component (Cloud, On-premise), By Enterprise Size (Small and Medium Enterprises (SMEs), Large Enterpr...

Artificial Intelligence (AI) In Predictive Toxicology Global Market Report 2025 – By Component (Solution, Services), By Technology (Machine Learning, Natural Language Processing, Computer Vision, Other Technologies), By ...

Frequently Asked Questions

What is the definition of the Artificial Intelligence In Drug Repurposing market?

How will the Artificial Intelligence In Drug Repurposing market drivers and restraints affect the market dynamics? What forces will shape the Artificial Intelligence In Drug Repurposing industry going forward?

The market major growth driver - Rising Demand For Precision Medicine Fueling The Growth Of The Market Due To Increasing Preference For Personalized And Targeted Therapies. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Artificial Intelligence In Drug Repurposing market?

The artificial intelligence in drug repurposing market size has grown exponentially in recent years. It will grow from $0.87 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to increasing prevalence of chronic and rare diseases, rising r&d expenditure, growing regulatory support, rising healthcare costs and increasing collaborations between pharma and ai firms. The artificial intelligence in drug repurposing market size is expected to see exponential growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to growing demand for cost-effective drug development, increasing use of ai-powered predictive analytics, rising prevalence of complex diseases, growing adoption of cloud infrastructure and increasing repurposing opportunities for existing approved drugs. Major trends in the forecast period include innovations in machine learning and generative ai applications, developments in predictive modeling and data analytics, technological advancements in large language models for hypothesis generation, innovations in cloud-based ai drug discovery platforms and technological enhancements in multi-omics data integration systems. For further insights on this market, request a sample here

How is the Artificial Intelligence In Drug Repurposing market segmented?

The artificial intelligence in drug repurposing market covered in this report is segmented –
1) By Component: Software And Platforms, Services
2) By Technology: Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision
3) By Deployment: Cloud-Based, On-Premises
4) By Therapeutic: Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases
5) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users Subsegments:
1) By Software And Platforms: Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools
2) By Services: Consulting Services, Data Management Services, Model Training And Optimization Services, Implementation And Integration Services, Support And Maintenance Services For further insights on this market, request a sample here

Which region has the largest share of the Artificial Intelligence In Drug Repurposing market? What are the other regions covered in the report?

North America was the largest region in the artificial intelligence in drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in drug repurposing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Who are the major players in the Artificial Intelligence In Drug Repurposing market?

What are the key trends in the Artificial Intelligence In Drug Repurposing market?

Major trends in this market include Accelerating Treatment Discovery Through Technology Integration. For further insights on this market, request a sample here.